CymitQuimica logo

CAS 74892-97-0

:

Cholesteryl 5,8,11,14,17-eicosapentaenoate

Description:
Cholesteryl 5,8,11,14,17-eicosapentaenoate is an ester formed from cholesterol and eicosapentaenoic acid, a polyunsaturated fatty acid. This compound is characterized by its hydrophobic nature due to the long hydrocarbon chain of the eicosapentaenoate moiety, which contributes to its role in lipid metabolism and cellular membrane structure. It is typically found in biological systems, particularly in lipid droplets and membranes, where it may influence membrane fluidity and signaling pathways. The presence of multiple double bonds in the eicosapentaenoate chain imparts unique properties, such as increased reactivity and potential for oxidation. Cholesteryl esters, including this compound, are important in the context of cardiovascular health, as they can be involved in cholesterol transport and metabolism. Additionally, they may play a role in the development of atherosclerosis when accumulated in arterial walls. Overall, cholesteryl 5,8,11,14,17-eicosapentaenoate serves as a significant biomolecule with implications in both health and disease.
Formula:C47H74O2
InChI:InChI=1S/C47H74O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-27-45(48)49-40-32-34-46(5)39(36-40)28-29-41-43-31-30-42(38(4)26-24-25-37(2)3)47(43,6)35-33-44(41)46/h8-9,11-12,14-15,17-18,20-21,28,37-38,40-44H,7,10,13,16,19,22-27,29-36H2,1-6H3/b9-8-,12-11-,15-14-,18-17-,21-20-/t38-,40+,41+,42-,43+,44+,46+,47-/m1/s1
InChI key:InChIKey=XZFUGMCJZFRBKF-BDJFIEMMSA-N
SMILES:C[C@@]12[C@@]3([C@]([C@]4([C@](C)(CC3)[C@@]([C@@H](CCCC(C)C)C)(CC4)[H])[H])(CC=C1C[C@@H](OC(CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)=O)CC2)[H])[H]
Synonyms:
  • Cholest-5-en-3-ol (3b)-, (all-Z)-5,8,11,14,17-eicosapentaenoate
  • Cholest-5-en-3-ol (3β)-, (5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-eicosapentaenoate
  • Cholest-5-en-3-ol(3b)-, (5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-eicosapentaenoate(9CI)
  • Cholesteryl 5,8,11,14,17-eicosapentaenoate
  • Cholesteryl5,8,11,14,17-eicosapentaenoate
  • Cholest-5-en-3-ol (3β)-, 3-[(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-eicosapentaenoate]
  • [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
  • CE(20:5(5Z,8Z,11Z,14Z,17Z)
  • CHOLESTERYL EICOSAPENTAENOATE
  • Cholesteryl eicosapentaenoic acid
  • cholesteryl (5Z,8Z,11Z,14Z,17Z-eicosapentaenoate)
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
  • CE(20:5(5Z,8Z,11Z,14Z,17Z)
    Targetmol
    + Info

    CE(20:5(5Z,8Z,11Z,14Z,17Z)

    CAS:
    CE(20:5(5Z,8Z,11Z,14Z,17Z) is an endogenous metabolite.
    Formula:C47H74O2
    Purity:98%
    Color and Shape:Solid
    Molecular weight:671.09

    Ref: TM-T10748

  • Cholesteryl Eicosapentaenoate
    Larodan
    + Info

    Cholesteryl Eicosapentaenoate

    CAS:
    Formula:C47H74O2
    Purity:>99%
    Molecular weight:671.09

    Ref: 48-64-2005

    25mg
    201.00€
  • Cholesteryl eicosapentaenoate
    Biosynth
    + Info

    Cholesteryl eicosapentaenoate

    Controlled Product
    CAS:
    <p>Cholesteryl eicosapentaenoate is a polyunsaturated fatty acid that is one of the main constituents of the lipid-soluble portion of human plasma. It can be found in the prostatic tissue, where it may play an important role in the development and progression of prostate hypertrophy. Cholesteryl eicosapentaenoate has been shown to inhibit phosphatidylcholine hydrolysis and glutamic acid release from prostatic tissue. The administration of cholesteryl eicosapentaenoate to humans has been shown to reduce symptoms associated with prostatic hypertrophy. This compound is used as a pharmaceutical preparation for treating organic acid disorders such as hypercholesterolemia and atherosclerosis.</p>
    Formula:C47H74O2
    Purity:Min. 95%
    Molecular weight:671.1 g/mol

    Ref: 3D-ZCA89297

    25mg
    1,037.00€
    50mg
    1,444.00€
    100mg
    2,250.00€